Cytokines as Immunomodulators in Tuberculosis Therapy

Publisher： Bentham Science Publishers

E-ISSN： 2212-4071|3|3|168-176

ISSN： 1574-891X

Source： Recent Patents on Anti-Infective Drug Discovery, Vol.3, Iss.3, 2008-01, pp. : 168-176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tuberculosis after anti-TNF therapy

By Pamuk Ömer   Dönmez Salim  

Clinical Rheumatology, Vol. 28, Iss. 6, 2009-06 ,pp. : 747-747

Springer Publishing Company

Access to resources Recommend Favorite

Inflammatory Cytokines and Atherosclerosis Possible Application for the Gene Therapy

By  

Vascular Disease Prevention, Vol. 2, Iss. 2, 2005-04 ,pp. : 115-120

Bentham Science Publishers

Access to resources Recommend Favorite

Miliary tuberculosis after infliximab therapy in Lebanon

By Uthman Imad   Kanj Nadim   El-Sayad Jinane   Bizri Abdul-Rahman  

Clinical Rheumatology, Vol. 23, Iss. 3, 2004-06 ,pp. : 279-280

Springer Publishing Company

Access to resources Recommend Favorite

When to Start Antiretroviral Therapy in HIV-Associated Tuberculosis

By  

Current Respiratory Medicine Reviews, Vol. 9, Iss. 3, 2013-06 ,pp. : 193-199

Bentham Science Publishers

Access to resources Recommend Favorite

Current Status of Anti-Tuberculosis Therapy: A Patent Analysis

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 9, Iss. 1, 2014-04 ,pp. : 25-40

Bentham Science Publishers

Access to resources Recommend Favorite